𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New Adaptive Method for Phase I Trials in Oncology

✍ Scribed by Meille, C; Gentet, JC; Barbolosi, D; André, N; Doz, F; Iliadis, A

Book ID
110020239
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
593 KB
Volume
83
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trials in paediatric oncology —
Phase I trials in paediatric oncology — the European perspective
✍ E. J. Estlin; S. Ablett; D. R. Newell; I. J. Lewis; L. Lashford; A. D. J. Pearso 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 881 KB

The current recommendations for Phase I trials should allow more confident interpretation of the toxicity and efficacy of new agents by providing a framework for multicentre and international co-operation. An overview of the aims and designs of Phase I trials is presented, along with a summary of cu

Continual reassessment methods in phase
Continual reassessment methods in phase I trials of the combination of two drugs in oncology
✍ Andrew Kramar; Anne Lebecq; Emmanuel Candalh 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Most phase I trials in oncology use standard methods for treating successive groups of patients with increasing doses in order to determine the maximum tolerated dose (MTD). These methods have been criticized because they treat many patients at suboptimal dose levels, and do not provide an accurate